Analystreport

Trillium Therapeutics Inc (NASDAQ: TRIL) was given a new $4.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Defiance Trillion Dollar Club Index ETF  (TRIL) 
Last defiance trillion dollar club index etf earnings: 5/13 07:00 am Check Earnings Report